NYSE - Nasdaq Real Time Price • USD
Edwards Lifesciences Corporation (EW)
At close: May 31 at 4:00 PM EDT
Pre-Market: 7:04 AM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 25 | 25 | 29 | 29 |
| Avg. Estimate | 0.69 | 0.69 | 2.76 | 3.12 |
| Low Estimate | 0.67 | 0.66 | 2.66 | 2.84 |
| High Estimate | 0.71 | 0.71 | 2.8 | 3.43 |
| Year Ago EPS | 0.66 | 0.59 | 2.51 | 2.76 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 24 | 24 | 30 | 30 |
| Avg. Estimate | 1.65B | 1.62B | 6.56B | 7.2B |
| Low Estimate | 1.63B | 1.59B | 6.48B | 6.97B |
| High Estimate | 1.67B | 1.65B | 6.62B | 7.36B |
| Year Ago Sales | 1.5B | 1.48B | 6B | 6.56B |
| Sales Growth (year/est) | 10.00% | 9.60% | 9.30% | 9.80% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.65 | 0.59 | 0.64 | 0.64 |
| EPS Actual | 0.66 | 0.59 | 0.64 | 0.66 |
| Difference | 0.01 | 0 | 0 | 0.02 |
| Surprise % | 1.50% | 0.00% | 0.00% | 3.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.69 | 0.69 | 2.76 | 3.12 |
| 7 Days Ago | 0.69 | 0.69 | 2.76 | 3.12 |
| 30 Days Ago | 0.69 | 0.69 | 2.76 | 3.11 |
| 60 Days Ago | 0.7 | 0.69 | 2.75 | 3.09 |
| 90 Days Ago | 0.7 | 0.69 | 2.75 | 3.09 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 2 | 3 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | EW | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 4.50% | -- | -- | 8.90% |
| Next Qtr. | 16.90% | -- | -- | 11.40% |
| Current Year | 10.00% | -- | -- | 5.80% |
| Next Year | 13.00% | -- | -- | 12.60% |
| Next 5 Years (per annum) | 10.72% | -- | -- | 11.45% |
| Past 5 Years (per annum) | 9.60% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Goldman Sachs: Buy | 5/30/2024 |
| Upgrade | Citigroup: Neutral to Buy | 5/22/2024 |
| Upgrade | Deutsche Bank: Hold to Buy | 5/14/2024 |
| Maintains | Barclays: Overweight to Overweight | 5/7/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 4/26/2024 |
| Maintains | Evercore ISI Group: In-Line to In-Line | 4/26/2024 |
Related Tickers
BSX Boston Scientific Corporation
75.57
+0.76%
SYK Stryker Corporation
341.09
+0.17%
MDT Medtronic plc
81.37
+0.96%
DXCM DexCom, Inc.
118.78
+0.32%
ZBH Zimmer Biomet Holdings, Inc.
115.15
+0.62%
ABT Abbott Laboratories
102.19
+0.44%
SWAV Shockwave Medical, Inc.
334.75
0.00%
ALGN Align Technology, Inc.
257.21
+0.28%
PODD Insulet Corporation
177.19
+0.70%
NARI Inari Medical, Inc.
50.00
-1.37%